GNPX
Closed
Genprex Inc
0.267
+0.039 (+17.11%)
Last Update: 01 Jul 2025 23:25:00
Yesterday: 0.2279
Day's Range: 0.2205 - 0.267
Send
sign up or login to leave a comment!
When Written:
0.8991
Genprex Inc is a clinical-stage gene therapy company that develops new therapies for cancer patients. The company's lead product candidate, Oncoprex, is a non-viral gene therapy that targets cancer cells and triggers programmed cell death. The company is also developing other gene therapies for lung cancer, including a combination therapy with Merck's Keytruda. Genprex was founded in 2009 and is headquartered in Austin, Texas. The company is listed on the NASDAQ exchange under the ticker symbol "GNPX".
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








